Neuphoria Therapeutics(DE:B1N0)
€1.610.00 (0.00%)
DE:B1N0
Neuphoria Therapeutics earnings date
€1.61
At close:0.00 (0.00%)
Neuphoria Therapeutics (B1N0) Q2 2021 Earnings Report
2 Followers
DE:B1N0 Q2 2021 EPS Results
- Actual EPS
- EUR 0.00
- Consensus EPS
- EUR 0.00
- Beat/Miss
- Met expectations
- One Year Ago EPS
- -EUR 0.98
DE:B1N0 Q2 2021 Revenue Results
- Actual Revenue
- EUR 64.41K
- Expected Revenue
- EUR 2.97M
- Beat/Miss
- Missed by -EUR 2.90M
- YoY Revenue Growth
- +6.82%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 02/26/2021
- Time
- Before Open
- Conference Call
- Friday, February 26, 2021
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:B1N0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Sep 29, 2025 | 2025 (Q4) | -1.82-2.31 | -25.64 | 91.00% (+23.33) | |
| Feb 20, 2025 | 2025 (Q2) | ―- | ― | ― | |
| Aug 21, 2024 | 2024 (Q4) | -0.83-0.83 | -0.93 | 10.23% (+0.09) | |
| Feb 22, 2024 | 2024 (Q2) | ―-0.93 | -1.29 | 28.10% (+0.36) | |
| Aug 23, 2023 | 2023 (Q4) | -0.98- | -1.01 | ― | |
| Feb 23, 2023 | 2023 (Q2) | -7.00-15.49 | -5.37 | -188.32% (-10.12) | |
| Aug 25, 2022 | 2022 (Q4) | ―-12.15 | -0.01 | -153677.78% (-12.14) | |
| Feb 22, 2022 | 2022 (Q2) | -10.79-5.37 | 0 | ― | |
| Aug 25, 2021 | 2021 (Q4) | 0.00-0.01 | 0 | ― | |
| Feb 26, 2021 | 2021 (Q2) | 0.000.00 | -0.98 | 100.00% (+0.98) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

